Your prediction
Coty Inc Stock
The price for the Coty Inc stock decreased slightly today. Compared to yesterday there is a change of -€0.020 (-0.850%).
Our community identified positive and negative aspects for Coty Inc stock for the coming years. 0 users see the criterium "EBIT growth" as a plus for the Coty Inc stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Coty Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Coty Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Coty Inc | -0.850% | 2.564% | 18.812% | -41.234% | -7.407% | -77.486% | -67.444% |
| Nu Skin Enterprises A | -0.620% | -0.445% | -3.952% | -36.114% | -45.463% | -83.061% | -90.045% |
| Spectrum Brands Holdings, Inc | -0.650% | -1.923% | 1.325% | 70.000% | 51.485% | 7.746% | 4.082% |
| Interparfums S.A. | 4.610% | 8.435% | 0.322% | -21.474% | 0.727% | -61.631% | -59.182% |
Comments
News
Coty Q3 Earnings Call Highlights
Coty (NYSE:COTY) executives said the beauty company is working to narrow the gap between retail sell-out and sell-in, sharpen its
Stock Market Today, Feb. 18: Kenvue Rises After Earnings Beat Expectations
Kenvue (NYSE:KVUE), maker of consumer health products including Tylenol, Neutrogena, and Listerine, closed Wednesday at $18.88, up 2.55%. The stock moved higher after Q4 results beat expectations
